Insider Selling: Cardlytics, Inc. (NASDAQ:CDLX) Director Sells 2,000 Shares of Stock

Cardlytics, Inc. (NASDAQ:CDLX) Director Scott D. Grimes sold 2,000 shares of the firm’s stock in a transaction that occurred on Friday, April 16th. The stock was sold at an average price of $124.07, for a total value of $248,140.00. Following the sale, the director now directly owns 251,827 shares of the company’s stock, valued at approximately $31,244,175.89. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Shares of Cardlytics stock opened at $118.01 on Wednesday. The company has a debt-to-equity ratio of 1.14, a quick ratio of 6.08 and a current ratio of 6.08. Cardlytics, Inc. has a 52 week low of $38.00 and a 52 week high of $161.47. The stock has a 50 day moving average price of $121.57 and a two-hundred day moving average price of $119.98. The stock has a market capitalization of $3.75 billion, a PE ratio of -70.24 and a beta of 2.63.

Cardlytics (NASDAQ:CDLX) last announced its earnings results on Sunday, February 28th. The company reported ($0.05) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.03) by ($0.02). The company had revenue of $67.08 million for the quarter, compared to analysts’ expectations of $60.84 million. Cardlytics had a negative net margin of 23.91% and a negative return on equity of 31.98%. The firm’s quarterly revenue was down 3.2% on a year-over-year basis. During the same period in the previous year, the firm earned $0.18 EPS. Research analysts forecast that Cardlytics, Inc. will post -2.08 EPS for the current year.

Several equities research analysts recently commented on CDLX shares. Wells Fargo & Company raised Cardlytics from an “equal weight” rating to an “overweight” rating and set a $150.00 target price for the company in a research note on Thursday, April 15th. Craig Hallum raised Cardlytics from a “hold” rating to a “buy” rating and set a $145.00 target price for the company in a research note on Tuesday. Bank of America raised Cardlytics from an “underperform” rating to a “neutral” rating and set a $128.00 target price for the company in a research note on Thursday, March 11th. William Blair cut Cardlytics from an “outperform” rating to a “market perform” rating in a research note on Thursday, January 14th. They noted that the move was a valuation call. Finally, Zacks Investment Research cut Cardlytics from a “hold” rating to a “sell” rating in a research note on Wednesday, February 10th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and three have given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus price target of $129.67.

Several large investors have recently made changes to their positions in the stock. FMR LLC boosted its position in shares of Cardlytics by 2.3% during the first quarter. FMR LLC now owns 3,284,572 shares of the company’s stock valued at $54,327,000 after buying an additional 72,847 shares during the last quarter. BlackRock Inc. lifted its holdings in Cardlytics by 4.2% during the fourth quarter. BlackRock Inc. now owns 2,048,867 shares of the company’s stock worth $292,517,000 after acquiring an additional 83,096 shares during the period. JPMorgan Chase & Co. lifted its holdings in Cardlytics by 105.7% during the fourth quarter. JPMorgan Chase & Co. now owns 1,451,294 shares of the company’s stock worth $207,202,000 after acquiring an additional 745,762 shares during the period. Lord Abbett & CO. LLC lifted its holdings in Cardlytics by 38.7% during the fourth quarter. Lord Abbett & CO. LLC now owns 780,503 shares of the company’s stock worth $111,432,000 after acquiring an additional 217,587 shares during the period. Finally, Water Island Capital LLC bought a new stake in Cardlytics during the fourth quarter worth $8,047,000. 97.03% of the stock is currently owned by institutional investors.

About Cardlytics

Cardlytics, Inc operates an advertising platform within financial institutions digital channels that include online, mobile, email, and various real-time notifications in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels.

See Also: What are retained earnings?

Insider Buying and Selling by Quarter for Cardlytics (NASDAQ:CDLX)

Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.